These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23849588)

  • 1. Predictive factors of risk of hepatocellular carcinoma in chronic hepatitis C.
    Gavilán JC; Ojeda G; Arnedo R; Puerta S
    Eur J Intern Med; 2013 Dec; 24(8):846-51. PubMed ID: 23849588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort.
    Paranaguá-Vezozzo DC; Ono SK; Alvarado-Mora MV; Farias AQ; Cunha-Silva M; França JI; Alves VA; Sherman M; Carrilho FJ
    Ann Hepatol; 2014; 13(4):386-93. PubMed ID: 24927609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models for hepatocellular carcinoma.
    Naveed M; Waljee AK; Singal AG
    Gastroenterology; 2014 May; 146(5):1420-1. PubMed ID: 24666822
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy.
    Narita Y; Genda T; Tsuzura H; Sato S; Kanemitsu Y; Ishikawa S; Kikuchi T; Hirano K; Iijima K; Wada R; Ichida T
    J Gastroenterol Hepatol; 2014 Jan; 29(1):137-43. PubMed ID: 24117602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
    Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
    Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
    Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
    Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence and risk factors for the development of hepatocellular carcinoma after peginterferon plus ribavirin therapy for chronic hepatitis C.
    Dohmen K; Kawano A; Takahashi K; Shigematsu H; Tanaka H; Haruno M; Yanagita K; Ichiki Y; Mori T; Hayashida K; Shimoda S; Ishibashi H; Nomura H
    Hepatogastroenterology; 2013; 60(128):2034-8. PubMed ID: 24719946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.
    Asahina Y; Tsuchiya K; Nishimura T; Muraoka M; Suzuki Y; Tamaki N; Yasui Y; Hosokawa T; Ueda K; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Enomoto N; Nakagawa M; Kakinuma S; Watanabe M; Izumi N
    Hepatology; 2013 Oct; 58(4):1253-62. PubMed ID: 23564522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA.
    El-Serag HB; Kramer JR; Chen GJ; Duan Z; Richardson PA; Davila JA
    Gut; 2011 Jul; 60(7):992-7. PubMed ID: 21257990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound screening for hepatocellular carcinoma in patients with advanced liver fibrosis. An overview.
    Dănilă M; Sporea I
    Med Ultrason; 2014 Jun; 16(2):139-44. PubMed ID: 24791845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
    Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
    J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases.
    Solmi L; Primerano AM; Gandolfi L
    Am J Gastroenterol; 1996 Jun; 91(6):1189-94. PubMed ID: 8651169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.